SOPHiA GENETICS SA CEO Ross Muken buys $137,188 of SOPH
The CEO paid an average of $6.86 a share, according to a Form 4 filed with the SEC on Nov 9.
SOPHiA GENETICS SA's chief executive officer, Ross Muken, bought 20,000 shares of the company's stock on the open market on Nov 6. The purchase, at an average of $6.86 a share, comes to about $140,000.
It is an open-market purchase (transaction code P) of common stock, the kind of trade insiders make with their own money. It is the insider's first open-market purchase of SOPH in at least 12 months.
The filing came 3 days after the trade. No other open-market purchase at SOPHiA GENETICS SA was reported in the previous 90 days.
Details from the SEC filing:
| Company | SOPHiA GENETICS SA (SOPH) |
|---|---|
| Insider | Ross Muken |
| Role | CEO |
| Transaction | Open-market purchase (code P) |
| Shares | 20,000 |
| Average price | $6.86 |
| Value | $137,188 |
| Trade date | Nov 6, 2026 |
| Filed with the SEC | Nov 9, 2026, 4:05 PM ET |
| Shares held after | 680,391 |
| Ownership | Direct |
| Rule 10b5-1 plan | Not marked in the filing |
See the detailed report on this SOPH purchase
Browse the latest insider buying · Follow SOPH for the next insider trade
Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.